Retinal vasculitis in systemic lupus erythematosus: an indication of active disease

  • Umi Kalthum Md Noh | umi_fizul@yahoo.com Department of Ophthalmology, Pusat Perubatan Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
  • Aida Zairani A. Zahidin Department of Ophthalmology, Pusat Perubatan Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
  • Then Kong Yong Department of Ophthalmology, Pusat Perubatan Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.

Abstract

A 26-year-old woman with a recent flare-up of systemic lupus erythematosus presented with peripheral retinal hemorrhages at a routine check-up. She is on a tapering dose of immunosuppressive agents. Her visual acuity was good. Fluorescein angiogram revealed vasculitic changes with capillary non-perfusion areas. A few weeks later, she developed cerebral lupus with advanced lupus nephritis. Immunosuppressive therapy was restarted and panretinal photocoagulation was delivered. Her visual acuity remained stable, despite development of a cataract from prednisolone therapy.

Downloads

Download data is not yet available.

Author Biography

Umi Kalthum Md Noh, Department of Ophthalmology, Pusat Perubatan Universiti Kebangsaan Malaysia, Kuala Lumpur

Lecturer and Ophthalmologist

Published
2012-05-15
Section
Case Reports
Keywords:
systemic lupus erythematosus, vasculitis, fluorescein angiogram, panretinal photocoagulation.
Statistics
Abstract views: 583

PDF: 332
HTML: 280
Share it

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

How to Cite
Md Noh, U. K., Zahidin, A. Z. A., & Yong, T. K. (2012). Retinal vasculitis in systemic lupus erythematosus: an indication of active disease. Clinics and Practice, 2(2), e54. https://doi.org/10.4081/cp.2012.e54